These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6768115)

  • 21. [Two cases of stage IV breast cancer with severe hypercalcemia].
    Ohsako T; Yamamoto Y; Kawazoe T; Inoue K; Nagamoto N; Yoshida Y; Nakahara O; Sakamoto N; Iwase H
    Gan To Kagaku Ryoho; 2006 Feb; 33(2):223-6. PubMed ID: 16484860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory effect of Carthamus tinctorius L. seed extracts on bone resorption mediated by tyrosine kinase, COX-2 (cyclooxygenase) and PG (prostaglandin) E2.
    Yuk TH; Kang JH; Lee SR; Yuk SW; Lee KG; Song BY; Kim CH; Kim DW; Dong IK; Lee TK; Lee CH
    Am J Chin Med; 2002; 30(1):95-108. PubMed ID: 12067102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enantiospecific, selective cyclooxygenase-2 inhibitors.
    Kozak KR; Prusakiewicz JJ; Rowlinson SW; Marnett LJ
    Bioorg Med Chem Lett; 2002 May; 12(9):1315-8. PubMed ID: 11965379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of diphosphonates in the therapy of osteolysis and malignant hypercalcemia].
    Delmas PD; Charhon SA; Chapuy MC; Meunier PJ
    Rev Rhum Mal Osteoartic; 1984 Dec; 51(11):663-6. PubMed ID: 6523018
    [No Abstract]   [Full Text] [Related]  

  • 25. Investigations using clinically relevant particles. Reference: Im et al., The effect of COX-2 inhibitors on periprosthetic osteolysis, Biomaterials 25, 269-275 (2004).
    Shanbhag A
    Biomaterials; 2005 Jul; 26(20):4349-50. PubMed ID: 15683659
    [No Abstract]   [Full Text] [Related]  

  • 26. Cyclooxygenase products of arachidonic acid metabolism by mouse bone in organ culture.
    Voelkel EF; Tashjian AH; Levine L
    Biochim Biophys Acta; 1980 Dec; 620(3):418-28. PubMed ID: 6786343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aromatase and COX-2 expression in human breast cancers.
    Brodie AM; Lu Q; Long BJ; Fulton A; Chen T; Macpherson N; DeJong PC; Blankenstein MA; Nortier JW; Slee PH; van de Ven J; van Gorp JM; Elbers JR; Schipper ME; Blijham GH; Thijssen JH
    J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):41-7. PubMed ID: 11850206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and catabolism of PGE2 by a nephroblastoma associated with hypercalcemia without bone metastases.
    Calò L; Cantaro S; Bertazzo L; Vianello A; Vido L; Borsatti A
    Cancer; 1984 Aug; 54(4):635-7. PubMed ID: 6331625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for a direct role of cyclo-oxygenase 2 in implant wear debris-induced osteolysis.
    Zhang X; Morham SG; Langenbach R; Young DA; Xing L; Boyce BF; Puzas EJ; Rosier RN; O'Keefe RJ; Schwarz EM
    J Bone Miner Res; 2001 Apr; 16(4):660-70. PubMed ID: 11315993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical trials in metastatic breast cancer to bone: past--present--future.
    Body JJ
    Can J Oncol; 1995 Dec; 5 Suppl 1():16-27. PubMed ID: 8853520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stereoisomeric relationships among anti-inflammatory activity, inhibition of platelet aggregation, and inhibition of prostaglandin synthetase.
    Gaut ZN; Baruth H; Randall LO; Ashley C; Paulsrud JR
    Prostaglandins; 1975 Jul; 10(1):59-66. PubMed ID: 807954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thiazole analogues of the NSAID indomethacin as selective COX-2 inhibitors.
    Woods KW; McCroskey RW; Michaelides MR; Wada CK; Hulkower KI; Bell RL
    Bioorg Med Chem Lett; 2001 May; 11(10):1325-8. PubMed ID: 11392547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiestrogens inhibit in vitro bone resorption stimulated by 1,25-dihydroxyvitamin D3 and the vitamin D3 analogs EB1089 and KH1060.
    Vink-van Wijngaarden T; Birkenhäger JC; Kleinekoort WM; van den Bemd GJ; Pols HA; van Leeuwen JP
    Endocrinology; 1995 Feb; 136(2):812-5. PubMed ID: 7835315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct and indirect actions of fibroblast growth factor 2 on osteoclastic bone resorption in cultures.
    Kawaguchi H; Chikazu D; Nakamura K; Kumegawa M; Hakeda Y
    J Bone Miner Res; 2000 Mar; 15(3):466-73. PubMed ID: 10750561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolism of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide by prostaglandin endoperoxide synthetase.
    Zenser TV; Mattammal MB; Davis BB
    Cancer Res; 1980 Jan; 40(1):114-8. PubMed ID: 6765914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostaglandin synthetase activity from human rheumatoid synovial microsomes. Effect of 'aspirin-like' drug therapy.
    Crook D; Collins AJ; Bacon PA; Chan R
    Ann Rheum Dis; 1976 Aug; 35(4):327-32. PubMed ID: 823876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypercalcemia in breast cancer: an echo of bone mobilization during lactation?
    DeMauro S; Wysolmerski J
    J Mammary Gland Biol Neoplasia; 2005 Apr; 10(2):157-67. PubMed ID: 16025222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of nimesulide and indometacin on COX-1 and COX-2: a comparative study.
    de Leval X; Dogné JM; Neven P; Labasse A; Delarge J; Reginster JY; Henrotin Y
    J Pharm Belg; 1999; 54(3):89-90. PubMed ID: 10431478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of indomethacin on human colorectal cancer cells HCT116 and SW480].
    Wang HM; Zhang GY
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Feb; 29(1):28-31. PubMed ID: 16136999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Humoral hypercalcemia of malignancy. Release of a prostaglandin-stimulating bone-resorbing factor in vitro by human transitional-cell carcinoma cells.
    Bringhurst FR; Bierer BE; Godeau F; Neyhard N; Varner V; Segre GV
    J Clin Invest; 1986 Feb; 77(2):456-64. PubMed ID: 3003159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.